Muscarinic cholinergic signaling and overactive bladder-like symptoms associated with invasive bladder cancer
Autor: | Shaojun Jian, Yuexian Wu, Wei Wei, Qiwei Cheng, You Li, Yong Tang, Xianlin Yi, Minggang Wang, Long Xu, Yunglong Li, Haoyuan Lu, Qinggui Meng, Wenchao Yu, Keji Xie |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2018 |
Předmět: |
0301 basic medicine
Cancer Research urologic and male genital diseases 03 medical and health sciences muscarinic receptor 0302 clinical medicine Muscarinic acetylcholine receptor medicine Progression-free survival Urothelium Bladder cancer Oncogene business.industry Cancer Articles medicine.disease Molecular medicine female genital diseases and pregnancy complications 030104 developmental biology Oncology Overactive bladder 030220 oncology & carcinogenesis Cancer research bladder cancer overactive bladder business |
Zdroj: | Oncology Letters |
ISSN: | 1792-1082 1792-1074 |
Popis: | The objective of the present study was to explore the association between muscarinic cholinergic signaling and urothelial bladder tumors. Possible associations among overactive bladder (OAB) symptoms and bladder tumors were retrospectively investigated using a multicenter Chinese database with prospectively collected data since 2010. Firstly, it was demonstrated that OAB symptoms, such as urgency, were more severe in patients with invasive bladder cancer and were associated with a reduced prognosis. Following this, muscarinic cholinergic receptor 3 (M3R) expression in urothelium was determined to be lower in invasive cancer tissue than in adjacent non-cancerous tissue, yet M3R upregulation was associated with a reduced progression free survival (PFS) time. Additionally, it was also demonstrated that muscarinic cholinergic receptor 2 (M2R) was upregulated in the sub-urothelium, and this was also associated with a reduced PFS time. Furthermore, it was determined that cholinesterase and acetylcholinesterase were lower in invasive cancer than in non-invasive cancer. In conclusion, the results indicated that M3R expression was downregulated in invasive bladder cancer, which may have a role as a protective anti-oncogene, in contrast to its oncogenic role in numerous other cancer types. Therefore, muscarinic cholinergic signaling may be a novel therapeutic target for treating bladder cancer. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |